Header

UZH-Logo

Maintenance Infos

Items where Subject is "04 Faculty of Medicine > Institute of Medical Virology"

Navigate back| Up a level
Export as
Number of items at this level: 240.

Pohl, M O; Recum-Knepper, von, Jessica; Rodriguez-Frandsen, Ariel; Lanz, Caroline; Yangüez, Emilio; Soonthornvacharin, Stephen; Wolff, Thorsten; Chanda, Sumit K; Stertz, Silke (2017). Identification of Polo-like kinases as potential novel drug targets for influenza A virus. Scientific Reports, 7(1):8629.

Shaw, Megan L; Stertz, S (2017). Role of Host Genes in Influenza Virus Replication. In: Shaw, Megan L; Stertz, S. Current Topics in Microbiology and Immunology. Berlin, Heidelberg: Springer, 1-39.

Akers, Isabel; Weber, Rainer; Sax, Hugo; Böni, Jürg; Trkola, Alexandra; Kuster, Stefan (2017). Influence of time to diagnosis of severe influenza on antibiotic use, length of stay, isolation precautions, and mortality: a retrospective study. Influenza and Other Respiratory Viruses, 11(4):337-344.

Brandenberg, Oliver F; Magnus, Carsten; Rusert, Peter; Günthard, Huldrych F; Regoes, Roland Robert; Trkola, Alexandra (2017). Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters. PLoS Pathogens, 13(5):e1006313.

Dobay, Maria Pamela; Stertz, Silke; Delorenzi, Mauro (2017). Context-based retrieval of functional modules in protein-protein interaction networks. Briefings in Bioinformatics:Epub ahead of print.

Kletenkov, K; Hoffmann, D; Böni, J; Yerly, S; Aubert, V; Schöni-Affolter, F; Struck, D; Verheyen, J; Klimkait, T (2017). Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors? Journal of Antimicrobial Chemotherapy, 72(3):866-875.

Beauparlant, David; Rusert, Peter; Magnus, Carsten; Kadelka, Claus; Weber, Jacqueline; Uhr, Therese; Zagordi, Osvaldo; Oberle, Corinna; Duenas-Decamp, Maria J; Clapham, Paul R; Metzner, Karin J; Günthard, Huldrych F; Trkola, Alexandra (2017). Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality. PLoS Pathogens, 13(3):e1006255.

Oberle, Corinna S; Magnus, Carsten; Joos, Beda; Rusert, Peter; Beauparlant, David; Kouyos, Roger; Trkola, Alexandra; Metzner, Karin J; Günthard, Huldrych F (2017). Reply to correspondence 'Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a "stochastic" process' by Gonzalez et al., Retrovirology 2017. Retrovirology, 14(1):14.

Huber, M; Metzner, K J; Geissberger, F D; Shah, C; Leemann, C; Klimkait, T; Böni, J; Trkola, A; Zagordi, O (2017). MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing. Journal of Virological Methods, 240:7-13.

Lewandowska, Dagmara W; Schreiber, Peter W; Schuurmans, Macé M; Ruehe, Bettina; Zagordi, Osvaldo; Bayard, Cornelia; Greiner, Michael; Geissberger, Fabienne D; Capaul, Riccarda; Zbinden, Andrea; Böni, Jürg; Benden, Christian; Mueller, Nicolas J; Trkola, Alexandra; Huber, Michael (2017). Metagenomic sequencing complements routine diagnostics in identifying viral pathogens in lung transplant recipients with unknown etiology of respiratory infection. PLoS ONE, 12(5):e0177340.

Marzel, Alex; Heinrich, Henriette; Schilliger, Lukas; Fehr, Jan S; Günthard, Huldrych F; Kouyos, Roger; Rampini, Silvana K (2017). Prescription of post-exposure prophylaxis for HIV-1 in the emergency room: correct transmission risk assessment remains challenging. Journal of Acquired Immune Deficiency Syndromes, 74(4):359-366.

Kovari, Helen; Rauch, Andri; Kouyos, Roger; Rougemont, Mathieu; Cavassini, Matthias; Schmid, Patrick; Stöckle, Marcel; Bernasconi, Enos; Weber, Rainer; Ledergerber, Bruno; Swiss HIV Cohort Study (2016). Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study. Clinical Infectious Diseases:Epub ahead of print.

Bader, J; Däumer, M; Schöni-Affolter, F; Böni, J; Gorgievski-Hrisoho, Meri; Martinetti, G; Thielen, A; Klimkait, T (2016). Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1. Clinical Infectious Diseases, 64(3):295-300.

Nigg, P E; Pavlovic, J (2016). Characterization of multi-subunit protein complexes of human mxa using non-denaturing polyacrylamide gel-electrophoresis. Journal of Visualized Experiments (Jove), 116:online.

Landtwing, Vanessa; Raykova, Ana; Pezzino, Gaetana; Béziat, Vivien; Marcenaro, Emanuela; Graf, Claudine; Moretta, Alessandro; Capaul, Riccarda; Zbinden, Andrea; Ferlazzo, Guido; Malmberg, Karl-Johan; Chijioke, Obinna; Münz, Christian (2016). Cognate HLA absence in trans diminishes human NK cell education. Journal of Clinical Investigation, 126(10):3772-3782.

Rusert, Peter; Kouyos, Roger D; Kadelka, Claus; Ebner, Hanna; Schanz, Merle; Huber, Michael; Braun, Dominique L; Hozé, Nathanael; Scherrer, Alexandra; Magnus, Carsten; Weber, Jacqueline; Uhr, Therese; Cippa, Valentina; Thorball, Christian W; Kuster, Herbert; Cavassini, Matthias; Bernasconi, Enos; Hoffmann, Matthias; Calmy, Alexandra; Battegay, Manuel; Rauch, Andri; Yerly, Sabine; Aubert, Vincent; Klimkait, Thomas; Böni, Jürg; Fellay, Jacques; Regoes, Roland R; Günthard, Huldrych F; Trkola, Alexandra (2016). Determinants of HIV-1 broadly neutralizing antibody induction. Nature Medicine, 22(11):1260-1267.

Ragonnet-Cronin, Manon L; Shilaih, Mohaned; Günthard, Huldrych F; Hodcroft, Emma B; Böni, Jürg; Fearnhill, Esther; Dunn, David; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Yang, Wan-Lin; Brown, Alison E; Lycett, Samantha J; Kouyos, Roger; Brown, Andrew J Leigh (2016). A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland. Scientific Reports, 6:32251.

Kiessling, Michael K; Schuierer, Sven; Stertz, Silke; Beibel, Martin; Bergling, Sebastian; Knehr, Judith; Carbone, Walter; de Vallière, Cheryl; Tchinda, Joelle; Bouwmeester, Tewis; Seuwen, Klaus; Rogler, Gerhard; Roma, Guglielmo (2016). Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening. BMC Genomics, 17(1):723.

Oberle, Corinna S; Joos, Beda; Rusert, Peter; Campbell, Nottania K; Beauparlant, David; Kuster, Herbert; Weber, Jacqueline; Schenkel, Corinne D; Scherrer, Alexandra U; Magnus, Carsten; Kouyos, Roger; Rieder, Philip; Niederöst, Barbara; Braun, Dominique L; Pavlovic, Jovan; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Trkola, Alexandra; Metzner, Karin J; Günthard, Huldrych F (2016). Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs. Retrovirology, 13(1):62.

Montazeri, Hesam; Kuipers, Jack; Kouyos, Roger; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Günthard, Huldrych F; Beerenwinkel, Niko (2016). Large-scale inference of conjunctive Bayesian networks. Bioinformatics, 32(17):i727-i735.

Pohl, M O; Lanz, C; Stertz, S (2016). Late stages of the influenza A virus replication cycle — a tight interplay between virus and host. Journal of General Virology, 97(9):2058 -2072.

Bader, J; Schöni-Affolter, F; Böni, Jürg; Gorgievski-Hrisoho, M; Martinetti, G; Battegay, M; Klimkait, T (2016). Correlating HIV tropism with immunological response under combination antiretroviral therapy. HIV Medicine, 17(8):615-622.

Diene, S M; François, P; Zbinden, A; Entenza, J M; Resch, G (2016). Comparative genomics analysis of streptococcus tigurinus strains identifies genetic elements specifically and uniquely present in highly virulent strains. PLoS ONE, 11(8):online.

Scherrer, Alexandra U; Yang, Wan-Lin; Kouyos, Roger D; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Cavassini, Matthias; Battegay, Manuel; Hauser, Christoph; Calmy, Alexandra; Schmid, Patrick; Bernasconi, Enos; Günthard, Huldrych F (2016). Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study. Journal of Infectious Diseases, 214(3):399-402.

Zbinden, A; Dürig, R; Shah, C; Böni, J; Schüpbach, J (2016). Importance of an Early HIV Antibody Differentiation Immunoassay for Detection of Dual Infection with HIV-1 and HIV-2. PLoS ONE, 11(6):online.

Shilaih, Mohaned; Marzel, Alex; Yang, Wan Lin; Scherrer, Alexandra U; Schüpbach, Jörg; Böni, Jürg; Yerly, Sabine; Hirsch, Hans H; Aubert, Vincent; Cavassini, Matthias; Klimkait, Thomas; Vernazza, Pietro L; Bernasconi, Enos; Furrer, Hansjakob; Günthard, Huldrych F; Kouyos, Roger (2016). Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland. Scientific Reports, 6:27580.

Scherrer, Alexandra U; von Wyl, Viktor; Yang, Wan-Lin; Kouyos, Roger D; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Cavassini, Matthias; Battegay, Manuel; Furrer, Hansjakob; Calmy, Alexandra; Vernazza, Pietro; Bernasconi, Enos; Günthard, Huldrych F (2016). Emergence of acquired HIV-1 drug resistance almost stopped in Switzerland: A 15-year prospective cohort analysis. Clinical Infectious Diseases, 62(10):1310-1317.

Marzel, Alex; Shilaih, Mohaned; Yang, Wan-Lin; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Braun, Dominique L; Calmy, Alexandra; Furrer, Hansjakob; Cavassini, Matthias; Battegay, Manuel; Vernazza, Pietro L; Bernasconi, Enos; Günthard, Huldrych F; Kouyos, Roger D; Swiss HIV Cohort Study (2016). HIV-1 transmission during recent infection and during treatment interruptions as major drivers of new infections in the Swiss HIV Cohort Study. Clinical Infectious Diseases, 62(1):115-122.

Stiegeler, Emanuel. HIV envelope specific DARPins as entry inhibitors. 2016, University of Zurich, Faculty of Medicine.

Magnus, C; Reh, L; Trkola, Alexandra (2016). HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution. Virus Research, 218:57-70.

Pohl, Marie-Theres. Identification of novel host factors of influenza A virus. 2016, University of Zurich, Faculty of Medicine.

Lewandowska, Dagmara Wanda. Metagenomic profiling of viral infections for improved virus diagnostic and infectious disease management in immune compromised patients. 2016, University of Zurich, Faculty of Medicine.

Reh, Lucia. The role of cell-cell transmission in steering HIV-1 neutralization and escape. 2016, University of Zurich, Faculty of Medicine.

Nigg, Patricia E; Pavlovic, Jovan (2015). Oligomerization and GTP-binding requirements of MxA for viral target recognition and antiviral activity against influenza a virus. Journal of Biological Chemistry, 290(50):29893-29906.

Tripathi, S; Pohl, M O; Zhou, Y; Rodriguez-Frandsen, A; Wang, G; Stein, D A; Moulton, H M; Che, J; Mulder, L C F; Yangüez, E; Andenmatten, D; Pache, L; Manicassamy, B; Albrecht, R A; Gonzalez, M G; Nguyen, Quy; Brass, A; Elledge, S; White, M; Shapira, S; Hacohen, N; Karlas, A; Meyer, T; Shales, M; Gatorano, A; Johnson, J R; Jang, G; Johnson, T; Verschueren, E; Sanders, D; Krogan, N; Shaw, M; König, R; Stertz, S; García-Sastre, A; Chanda, S K; DeJesus, P (2015). Meta- and orthogonal integration of influenza "OMICs" data defines a role for UBR4 in virus budding. Cell Host & Microbe, 18(6):723-735.

Brandenberg, Oliver F; Magnus, Carsten; Regoes, Roland R; Trkola, Alexandra (2015). The HIV-1 entry process: A stoichiometric view. Trends in Microbiology, 23(12):763-774.

Domingues, P; Golebiowski, F; Tatham, M H; Lopes, A M; Taggart, A; Hay, R T; Hale, B G (2015). Global Reprogramming of Host SUMOylation during Influenza Virus Infection. Cell Reports, 13(7):1467-1480.

Schultze, Detlev; Mani, Bernhard; Dollenmaier, Günter; Sahli, Roland; Zbinden, Andrea; Krayenbühl, A (2015). Acute Hepatitis E Virus infection with coincident reactivation of Epstein-Barr virus infection in an immunosuppressed patient with rheumatoid arthritis: a case report. BMC Infectious Diseases, 15(474):online.

Vetter, Beatrice N; Orlowski, Vanessa; Niederhauser, Christoph; Walter, Louise; Schüpbach, J (2015). Impact of naturally occurring amino acid variations on the detection of HIV-1 p24 in diagnostic antigen tests. BMC Infectious Diseases, 15(468):online.

Vetter, B N; Orlowski, V; Schüpbach, J; Boeni, J; Ruehe, B; Huder, J B (2015). Resolution of plasma sample mix-ups through comparison of patient antibody patterns to E. coli. Journal of Immunological Methods, 427:130-133.

Glass, Tracy R; Sterne, Jonathan A C; Schneider, Marie-Paule; De Geest, Sabina; Nicca, Dunja; Furrer, Hansjakob; Günthard, Huldrych F; Bernasconi, Enos; Calmy, Alexandra; Rickenbach, Martin; Battegay, Manuel; Bucher, Heiner C (2015). Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality. AIDS, 29(16):2195-200.

Montazeri, Hesam; Günthard, Huldrych F; Yang, Wan-Lin; Kouyos, Roger; Beerenwinkel, Niko (2015). Estimating the dynamics and dependencies of accumulating mutations with applications to HIV drug resistance. Biostatistics, 16(4):713-726.

Turkington, H L; Juozapaitis, M; Kerry, P S; Aydillo, T; Ayllon, J; García-Sastre, A; Schwemmle, M; Hale, B G (2015). Novel bat influenza virus NS1 proteins bind double-stranded RNA and antagonize host innate immunity. Journal of Virology, 89(20):10696-10701.

Braun, Dominique L; Kouyos, Roger D; Balmer, Belinda; Grube, Christina; Weber, Rainer; Günthard, Huldrych F (2015). Frequency and spectrum of unexpected clinical manifestations of primary HIV-1 infection. Clinical Infectious Diseases, 61(6):1013-1021.

Yang, Wan-Lin; Kouyos, Roger D; Scherrer, Alexandra U; Böni, Jürg; Shah, Cyril; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Hirzel, Cédric; Battegay, Manuel; Cavassini, Matthias; Bernasconi, Enos; Vernazza, Pietro; Held, Leonhard; Ledergerber, Bruno; Günthard, Huldrych F (2015). Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the swiss HIV cohort study. Journal of Antimicrobial Chemotherapy:3323-3331.

Kouyos, Roger D; Günthard, Huldrych F (2015). Editorial commentary: the irreversibility of HIV drug resistance. Clinical Infectious Diseases, 61(5):837-839.

Swiss HIV Cohort Study; Kovari, Helen; Ledergerber, Bruno; et al (2015). High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013. Journal of Hepatology, 63(3):573-580.

Benson, R A; MacLeod, M KL; Hale, B G; Patakas, A; Garside, P; Brewer, J M (2015). Antigen presentation kinetics control T cell/dendritic cell interactions and follicular helper T cell generation in vivo. eLife, 4:e06994.

Schüpbach, J; Niederhauser, C; Yerly, S; Regenass, S; Gorgievski, M; Aubert, V; Ciardo, D; Klimkait, T; Dollenmaier, G; Andreutti, C; Martinetti, G; Brandenberger, M; Gebhardt, M D (2015). Decreasing proportion of recent infections among newly diagnosed HIV-1 cases in Switzerland, 2008 to 2013 based on line-immunoassay-based algorithms. PLoS ONE, 10(7):e0131828.

Zhou, Q; Uhlig, K M; Muth, A; Kimpel, J; Lévi, C; Münch, R C; Seifried, J; Pfeiffer, A; Trkola, A; Coulibaly, C; von Laer, D; Wels, W S; Hartwig, U F; Verhoeyen, E; Buchholz, C J (2015). Exclusive transduction of human CD4+ T Cells upon systemic delivery of CD4-targeted lentiviral vectors. Journal of Immunology, (195):2493-2501.

Reh, Lucia; Magnus, Carsten; Schanz, Merle; Weber, Jacqueline; Uhr, Therese; Rusert, Peter; Trkola, Alexandra (2015). Capacity of broadly neutralizing antibodies to inhibit HIV-1 cell-cell transmission is strain- and epitope-dependent. PLoS Pathogens, 11(7):e1004966.

Yang, Wan-Lin; Kouyos, Roger; Scherrer, Alexandra U; Böni, Jürg; Shah, Cyril; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Furrer, Hansjakob; Battegay, Manuel; Cavassini, Matthias; Bernasconi, Enos; Vernazza, Pietro; Held, Leonhard; Ledergerber, Bruno; Günthard, Huldrych F; Swiss HIV Cohort Study (2015). Assessing the paradox between transmitted and acquired HIV type 1 drug resistance mutations in the Swiss HIV cohort study from 1998 to 2012. Journal of Infectious Diseases, 212(1):28-38.

Ussher, James E; Phalora, Prabhjeet; Cosgrove, Cormac; Hannaway, Rachel F; Rauch, Andri; Günthard, Huldrych F; Goulder, Philip; Phillips, Rodney E; Willberg, Christian B; Klenerman, Paul (2015). Molecular analyses define Vα7.2-Jα33+ MAIT cell depletion in HIV infection: a case-control study. Medicine, 94(29):e1134.

König, R; Stertz, S (2015). Recent strategies and progress in identifying host factors involved in virus replication. Current Opinion in Microbiology, (26):79-88.

Kohler, I; Kouyos, R D; Bianchi, M; Grube, C; Wyrzucki, A; Gunthard, H F; Hangartner, L (2015). The impact of vaccination on the breadth and magnitude of the antibody response to influenza A viruses in HIV-infected individuals. AIDS, 29(14):1803-1810.

Edinger, T O; Pohl, M O; Yangüez, E; Stertz, S (2015). Cathepsin W is required for escape of influenza a virus from late endosomes. mBio, 6(3):e00297-15.

Nigg, P E. The human MxA protein changes its stoichiometry and conformation upon GTP binding and targets influenza A virus nucleoprotein in its dimeric form. 2015, University of Zurich, Faculty of Science.

Pohl, M O; Stertz, S (2015). Measuring attachment and internalization of influenza a virus in A549 cells by flow cytometry. Journal of Visualized Experiments (Jove), (105):e53372.

Swiss HIV Cohort Study; Kouyos, R D; Hasse, B; et al (2015). Increases in condomless sex in the swiss HIV cohort study. Open Forum Infectious Diseases, 2(2):1-4.

Wyrzucki, Arkadiusz; Bianchi, Matteo; Kohler, Ines; Steck, Marco; Hangartner, Lars (2015). Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies. Journal of Virology, 89(6):3136-3144.

Yang, Wan-Lin; Kouyos, Roger D; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Scherrer, Alexandra U; Shilaih, Mohaned; Hinkley, Trevor; Petropoulos, Christos; Bonhoeffer, Sebastian; Günthard, Huldrych F (2015). Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds. PLoS Pathogens, 11(3):e1004722.

Edinger, T O. The Human Host Factor Cathepsin W is Required for Escape of Influenza A Virus From Late Endosomes. 2015, University of Zurich, Faculty of Science.

Schanz, M. Tracing Evolution of HIV-1 Neutralizing Antibodies and their Targets, the HIV-1 Envelope Proteins. 2015, University of Zurich, Faculty of Science.

Brandenberg, Oliver F; Magnus, Carsten; Rusert, Peter; Regoes, Roland R; Trkola, Alexandra (2015). Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry. PLoS Pathogens, 11(1):e1004595.

Zimmermann, Kathrin; Bastidas, Sonia; Knecht, Leandra; Kuster, Herbert; Vavricka, Stephan R; Günthard, Huldrych F; Oxenius, Annette (2015). Gut commensal microbes do not represent a dominant antigenic source for continuous CD4+T-cell activation during HIV-1 infection. European Journal of Immunology, 45(11):3107-3113.

Vongrad, Valentina; Imig, Jochen; Mohammadi, Pejman; Kishore, Shivendra; Jaskiewicz, Lukasz; Hall, Jonathan; Günthard, Huldrych F; Beerenwinkel, Niko; Metzner, Karin J (2015). HIV-1 RNAs are not part of the argonaute 2 associated RNA interference pathway in macrophages. PLoS ONE, 10(7):e0132127.

Birger, Ruthie; Kouyos, Roger; Dushoff, Jonathan; Grenfell, Bryan (2015). Modeling the effect of HIV coinfection on clearance and sustained virologic response during treatment for hepatitis C virus. Epidemics, 12:1-10.

Münch, Robert C; Muth, Anke; Muik, Alexander; Friedel, Thorsten; Schmatz, Julia; Dreier, Birgit; Trkola, Alexandra; Plückthun, Andreas; Büning, Hildegard; Buchholz, Christian J (2015). Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors. Nature Communications, 6:6246.

Lanz, C; Yangüez, E; Andenmatten, D; Stertz, S (2015). Swine IFITM proteins potently inhibit influenza A virus replication. Journal of Virology, 89(1):863-869.

Zbinden, A; Bostanci, N; Belibasakis, G N (2015). The novel species Streptococcus tigurinus and its association with oral infection. Virulence, 6(3):177-182.

Zimmermann, Kathrin; Liechti, Thomas; Haas, Anna; Rehr, Manuela; Trkola, Alexandra; Günthard, Huldrych F; Oxenius, Annette (2015). The orientation of HIV-1 gp120 binding to the CD4 receptor differentially modulates CD4+ T cell activation. Journal of Immunology, 194(2):637-649.

White, K M; De Jesus, P; Chen, Z; Abreu Jr, P; Barile, E; Mak, P A; Anderson, P; Nguyen, Q T; Inoue, A; Stertz, S; Koenig, R; Pellecchia, M; Palese, P; Kuhen, K; García-Sastre, A; Chanda, S K; Shaw, M L (2014). A potent anti-influenza compound blocks fusion through stabilization of the prefusion conformation of the hemagglutinin protein. ACS Infectious Diseases, 1:98-109.

Schanz, Merle; Liechti, Thomas; Zagordi, Osvaldo; Miho, Enkelejda; Reddy, Sai T; Günthard, Huldrych F; Trkola, Alexandra; Huber, Michael (2014). High-throughput sequencing of human immunoglobulin variable regions with subtype identification. PLoS ONE, 9(11):e111726.

Vetter, B N; Orlowski, V; Fransen, K; Niederhauser, C; Aubert, V; Brandenberger, M; Ciardo, D; Dollenmaier, G; Klimkait, T; Regenass, S; Schmid, P; Schottstedt, V; Suter-Riniker, F; Yerly, S; Shah, C; Böni, J; Schüpbach, J (2014). Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Test. PLoS ONE, 9(10):e111552-e111552.

Trkola, A (2014). Potency needs constancy. Nature, 514(7523):442-443.

Metzner, K J; Scherrer, A U; von Wyl, V; Böni, J; Yerly, S; Klimkait, T; Aubert, V; Furrer, H; Hirsch, H; Vernazza, P L; Cavassini, M; Calmy, A; Bernasconi, E; Weber, R; Gunthard, H F (2014). Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. AIDS, 28(15):2231-2239.

Kohler, Ines; Scherrer, A U; Zagordi, O; Bianchi, M; Wyrzucki, A; Steck, M; Ledergerber, B; Gunthard, H F; Hangartner, L (2014). Prevalence and predictors for homo- and heterosubtypic antibodies against influenza a virus. Clinical Infectious Diseases, 59(10):1386-1393.

Kouyos, R D; Rauch, A; Braun, D L; Yang, W-L; Böni, J; Yerly, S; Klimkait, T; Aubert, V; Shah, C; Kovari, H; Calmy, A; Cavassini, M; Battegay, M; Vernazza, P L; Bernasconi, E; Ledergerber, B; Gunthard, H F (2014). Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide. Journal of Infectious Diseases, 210(10):1555-1561.

Braun, D L; Rauch, A; Durisch, N; Eberhard, N; Anagnostopoulos, A; Ledergerber, B; Metzner, K J; Böni, J; Weber, R; Fehr, J (2014). Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients. HIV Medicine, 15:625-630.

Brandenberg, O F. Mechanisms of HIV Entry and Neutralization. 2014, University of Zurich, Faculty of Medicine.

Wyrzucki, A; Dreyfus, C; Kohler, I; Steck, M; Wilson, I A; Hangartner, L (2014). Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3-30-Encoded Heterosubtypic Antibody. Journal of Virology, 88(12):7083-7092.

Avila, Dorita; Keiser, Olivia; Egger, Matthias; Kouyos, Roger; Böni, Juerg; Yerly, Sabine; Klimkait, Thomas; Vernazza, Pietro L; Aubert, Vincent; Rauch, Andri; Bonhoeffer, Sebastian; Guenthard, Huldrych F; Stadler, Tanja; Spycher, Ben D (2014). Social Meets Molecular: Combining Phylogenetic and Latent Class Analyses to Understand HIV-1 Transmission in Switzerland. American Journal of Epidemiology, 179(12):1514-1525.

Vetter, B N; Shah, C; Huder, J B; Böni, J; Schüpbach, J (2014). Use of reverse-transcriptase-based HIV-1 viral load assessment to confirm low viral loads in newly diagnosed patients in Switzerland. BMC Infectious Diseases, 14:84.

Swenson, L C; Cobb, B; Geretti, A M; et al; Böni, J (2014). Comparative Performances of HIV-1 RNA Load Assays at Low Viral Load Levels: Results of an International Collaboration. Journal of Clinical Microbiology, 52(2):517-523.

Schuurmans, M M; Isenring, B D; Jungo, C; Boeni, J; Mueller, N J; Kohler, M; Benden, C (2014). Clinical features and outcomes of influenza infections in lung transplant recipients: a single-season cohort study. Transplant Infectious Disease, 16(3):430-439.

Kouyos, Roger D; Rauch, Andri; Böni, Jürg; Yerli, Sabome; Shah, Cyril; Aubert, Vincent; Klimkait, Thomas; Kovari, Helen; Calmy, Alexandra; Cavassini, Matthias; Battegay, Manuel; Vernazza, Pietro L; Bernasconi, Enos; Ledergerber, Bruno; Gunthard, Huldrych F (2014). Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV. International Journal of Epidemiology, 43(3):887-896.

Boenzli, Eva; Hadorn, Maik; Hartnack, Sonja; Huder, Jon; Hofmann-Lehmann, Regina; Lutz, Hans (2014). Detection of antibodies to the feline leukemia Virus (FeLV) transmembrane protein p15E: an alternative approach for serological FeLV detection based on antibodies to p15E. Journal of Clinical Microbiology, 52(6):2046-2052.

Schüpbach, Jörg; Berger, Christoph; Böni, Jürg; Speck, Roberto F (2014). HIV-Diagnostik in der Schweiz und ärztlicher Abklärungsgang von HIV-Infizierten. Therapeutische Umschau. Revue thérapeutique, 71(8):451-460.

Brandenberg, Oliver F; Rusert, Peter; Magnus, Carsten; Weber, Jacqueline; Böni, Jürg; Günthard, Huldrych F; Regoes, Roland R; Trkola, Alexandra (2014). Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain’s exceptional capacity for sequence variation. Retrovirology, 11:75.

Pohl, M O; Edinger, T O; Stertz, S (2014). Prolidase is required for early trafficking events during influenza a virus entry. Journal of Virology, 88(19):11271-11283.

Drescher, Sara M; von Wyl, Viktor; Yang, Wan-Lin; Böni, Jürg; Yerly, Sabine; Shah, Cyril; Aubert, Vincent; Klimkait, Thomas; Taffé, Patrick; Furrer, Hansjakob; Battegay, Manuel; Ambrosioni, Juan; Cavassini, Matthias; Bernasconi, Enos; Vernazza, Pietro L; Ledergerber, Bruno; Günthard, Huldrych F; Kouyos, Roger D (2014). Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study. Clinical Infectious Diseases, 58(2):285-294.

Magnus, Carsten; Brandenberg, Oliver F; Rusert, Peter; Trkola, Alexandra; Regoes, Roland Robert (2013). Mathematical models: a key to understanding HIV envelope interactions? Journal of Immunological Methods, 398-399:1-18.

Schüpbach, J (2013). Das schweizerische HIV Testkonzept – eine aktualisierte Übersicht. Bulletin Bundesamt für Gesundheit:6-14.

Huber, Michael; Böni, Jürg; Trkola, Alexandra (2013). Molekulare virologische Diagnostik im Wandel: Next Generation Sequencing auf dem Weg in die diagnostische Routine? Pipette, 5:15-17.

Schüpbach, J; Gebhardt, M D; Scherrer, A U; Bisset, L R; Niederhauser, C; Regenass, S; Yerly, S; Aubert, V; Suter, F; Pfister, S; Martinetti, G; Andreutti, C; Klimkait, T; Brandenberger, M; Gunthard, H F (2013). Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns. PLoS ONE, 8(8):e71662.

Lohrmann, F; Dijkman, R; Stertz, S; Thiel, V; Haller, O; Staeheli, P; Kochs, G (2013). Emergence of a C-terminal seve 1 n amino acid elongation of NS1 around 1950 2 conferred a minor growth advantage to former seasonal influenza A viruses. Journal of Virology, 87(20):11300-11303.

Medina, R A; Stertz, S; Manicassamy, C; Zimmermann, P; Sun, X; Albrecht, R A; Uusi-Kerttula, H; Zagordi, O; Belshe, R B; Frey, S E; Tumpey, T M; García-Sastre, A (2013). Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses. Science Translational Medicine, 5(187):187ra70.

Alamares-Sapuay, J G; Martinez-Gil, L; Stertz, S; Miller, M S; Shaw, M L; Palese, P (2013). Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza A virus. Journal of Virology, 87(10):6020-6026.

Hoot, Sam; McGuire, Andrew T; Cohen, Kristen W; Strong, Roland K; Hangartner, Lars; Klein, Florian; Diskin, Ron; Scheid, Johannes F; Sather, D Noah; Burton, Dennis R; Stamatatos, Leonidas (2013). Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs. PLoS Pathogens, 9(1):e003106.

Wyrzucki, Arkadiusz. Characterization of influenza a neutralizing, heterosubtypic antibodies isolated with a newly developed antigen. 2013, University of Zurich, Faculty of Science.

Edinger, T O; Pohl, M O; Stertz, S (2013). Entry of influenza A virus: host factors and antiviral targets. Journal of General Virology, 95:263-277.

Kohler, Ines. Prevalence and predictors for homo - and heterosubtypic antibodies against influenza a virus. 2013, University of Zurich, Faculty of Science.

Ota, Takayuki; Doyle-Cooper, Colleen; Cooper, Anthony B; Huber, Michael; Falkowska, Emilia; Doores, Katherine J; Hangartner, Lars; Le, Khoa; Sok, Devin; Jardine, Joseph; Lifson, Jeffrey; Wu, Xueling; Mascola, John R; Poignard, Pascal; Binley, James M; Chakrabarti, Bimal K; Schief, William R; Wyatt, Richard T; Burton, Dennis R; Nemazee, David (2012). Anti-HIV B cell lines as candidate vaccine biosensors. Journal of Immunology, 189:4816-4824.

Schüpbach, J; Bisset, L R; Gebhardt, M D; Regenass, S; Bürgisser, P; Gorgievski, M; Klimkait, T; Andreutti, C; Martinetti, G; Niederhauser, C; Yerly, S; Pfister, S; Schultze, D; Brandenberger, M; Schöni-Affolter, F; Scherrer, A U; Gunthard, H F (2012). Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection. BMC Infectious Diseases, 12(88):1471-2334.

Reynell, Lucie; Trkola, Alexandra (2012). HIV vaccines: an attainable goal? Swiss Medical Weekly, 142:online.

Abela, Irene A; Berlinger, Livia; Schanz, Merle; Reynell, Lucy; Günthard, Huldrych F; Rusert, Peter; Trkola, Alexandra (2012). Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies. PLoS Pathogens, 8(4):e1002634.

Mann, Axel M. HIV entry and its inhibition. 2012, University of Zurich, Faculty of Science.

Mekker, Andrea; Tchang, Vincent S; Haeberli, Lea; Oxenius, Annette; Trkola, Alexandra; Karrer, Urs (2012). Immune senescence: relative contributions of age and cytomegalovirus infection. PLoS Pathogens, 8(8):e1002850.

von Wyl, V; Yerly, S; Böni, J; Shah, C; Cellerai, C; Klimkait, T; Battegay, M; Bernasconi, E; Cavassini, M; Furrer, H; Hirschel, B; Vernazza, P L; Ledergerber, B; Günthard, H F (2012). Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations. Clinical Infectious Diseases, 54(1):131-140.

Leventhal, Gabriel E; Kouyos, Roger; Stadler, Tanja; von Wyl, Viktor; Yerly, Sabine; Böni, Jürg; Cellerai, Cristina; Klimkait, Thomas; Günthard, Huldrych F; Bonhoeffer, Sebastian (2012). Inferring epidemic contact structure from phylogenetic trees. PLoS Computational Biology, 8(3):e1002413.

Scherrer, Alexandra U; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L; Bernasconi, Enos; Ledergerber, Bruno; Günthard, Huldrych F (2012). Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens. PLoS ONE, 7(11):e50307.

Scherrer, Alexandra U; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Cellerai, Cristina; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L; Bernasconi, Enos; Günthard, Huldrych F (2012). Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PLoS ONE, 7(6):e37983.

Scherrer, A U; von Wyl, V; Götte, M; Klimkait, T; Cellerai, C; Yerly, S; Böni, J; Held, L; Ledergerber, B; Günthard, H F (2012). Polymorphic mutations associated with the emergence of the multi-nucleoside/tide resistance mutations 69 insertion and Q151M. Journal of Acquired Immune Deficiency Syndromes, 59(2):105-112.

Ludersdorfer, Thomas. Rack1 is required for interferon induced expression of secondary response genes and influenza a virus entry. 2012, University of Zurich, Faculty of Science.

Althaus, Claudia F; Vongrad, Valentina; Niederöst, Barbara; Joos, Beda; Di Giallonardo, Francesca; Rieder, Philip; Pavlovic, Jovan; Trkola, Alexandra; Günthard, Huldrych F; Metzner, Karin J; Fischer, Marek (2012). Tailored enrichment strategy detects low abundant small noncoding RNAs in HIV-1 infected cells. Retrovirology, 9:27.

Abela, Irene A. The role of neutralizing antibodies in inhibition of cell-cell transmission. 2012, University of Zurich, Faculty of Science.

Riedel, T; Ghasparian, A; Moehle, K; Rusert, P; Trkola, A; Robinson, J A (2011). Synthetic virus-like particles and conformationally constrained peptidomimetics in vaccine design. ChemBioChem, 12(18):2829-2836.

Wisskirchen, C; Ludersdorfer, T H; Müller, D A; Moritz, E; Pavlovic, J (2011). Interferon-induced antiviral protein MxA interacts with the cellular RNA helicases UAP56 and URH49. Journal of Biological Chemistry, 286(40):34743-34751.

Damond, F; Benard, A; Balotta, C; Böni, J; Cotten, M; Duque, V; Ferns, B; Garson, J; Gomes, P; Gonçalves, F; Gottlieb, G; Kupfer, B; Ruelle, J; Rodes, B; Soriano, V; Wainberg, M; Taieb, A; Matheron, S; Chene, G; Brun-Vezinet, F (2011). An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study. Journal of Clinical Microbiology, 49(10):3491-3497.

Wisskirchen, C; Ludersdorfer, T H; Müller, D A; Moritz, E; Pavlovic, J (2011). The cellular RNA helicase UAP56 is required for prevention of double-stranded RNA formation during influenza A virus infection. Journal of Virology, 85(17):8646-8655.

Kouyos, R D; von Wyl, V; Yerly, S; Böni, J; Rieder, P; Joos, B; Taffé, P; Shah, C; Bürgisser, P; Klimkait, T; Weber, R; Hirschel, B; Cavassini, M; Rauch, A; Battegay, M; Vernazza, P L; Bernasconi, E; Ledergerber, B; Bonhoeffer, S; Günthard, H F (2011). Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clinical Infectious Diseases, 52(4):532-539.

Oufir, M; Bisset, L R; Hoffmann, S R K; Xue, G; Klauser, S; Bergamaschi, B; Gervaix, A; Böni, J; Schüpbach, J; Gutte, B (2011). Artificial 64-residue HIV-1 enhancer-binding peptide is a potent inhibitor of viral replication in HIV-1-infected cells. Advances in Virology, 2011:165871.

Kouyos, R D; von Wyl, V; Hinkley, T; Petropoulos, C J; Haddad, M; Whitcomb, J M; Böni, J; Yerly, S; Cellerai, C; Klimkait, T; Günthard, H F; Bonhoeffer, S (2011). Assessing predicted HIV-1 replicative capacity in a clinical setting. PLoS Pathogens, 7(11):e1002321.

Wunderli, W; Meerbach, A; Guengoer, T; Berger, C; Greiner, O; Caduff, R; Trkola, A; Bossart, W; Gerlach, D; Schibler, M; Cordey, S; McKee, T A; Van Belle, S; Kaiser, L; Tapparel, C (2011). Astrovirus infection in hospitalized infants with severe combined immunodeficiency after allogeneic hematopoietic stem cell transplantation. PLoS ONE, 6(11):e27483.

Rieder, P; Joos, B; Scherrer, A U; Kuster, H; Braun, D; Grube, C; Niederöst, B; Leemann, C; Gianella, S; Metzner, K J; Böni, J; Weber, R; Günthard, H F (2011). Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection. Clinical Infectious Diseases, 53(12):1271-1279.

Mekker, A. Cytomegalovirus infection and immune senescence: an example of collateral damage. 2011, University of Zurich, Faculty of Science.

Young, J; Scherrer, A; Günthard, H; Opravil, M; Yerly, S; Böni, J; Rickenbach, M; Fux, C; Cavassini, M; Bernasconi, E; Vernazza, P; Hirschel, B; Battegay, M; Bucher, H (2011). Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Medicine, 12(5):299-307.

Schüpbach, J; Bisset, L R; Regenass, S; Bürgisser, P; Gorgievski, M; Steffen, I; Andreutti, C; Martinetti, G; Shah, C; Yerly, S; Klimkait, T; Gebhardt, M; Schöni-Affolter, F; Rickenbach, M (2011). High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC Infectious Diseases, 11(1):254.

Scherrer, A U; Ledergerber, B; von Wyl, V; Böni, J; Yerly, S; Klimkait, T; Bürgisser, P; Rauch, A; Hirschel, B; Cavassini, M; Elzi, L; Vernazza, P L; Bernasconi, E; Held, L; Günthard, H F (2011). Improved virological outcome in white patients infected with HIV-1 non-B subtypes compared to subtype B. Clinical Infectious Diseases, 53(11):1143-1152.

Rusert, P; Krarup, A; Magnus, C; Brandenberg, O F; Weber, J; Ehlert, A K; Regoes, R R; Günthard, H F; Trkola, A (2011). Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies. Journal of Experimental Medicine, 208(7):1419-1433.

Ruprecht, C R; Krarup, A; Reynell, L; Mann, A M; Brandenberg, O F; Berlinger, L; Abela, I A; Regoes, R R; Günthard, H F; Rusert, P; Trkola, A (2011). MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1. Journal of Experimental Medicine, 208(3):439-454.

Bansal, V; Metzner, K J; Niederost, B; Leemann, C; Böni, J; Gunthard, H F; Fehr, J S (2011). Minority K65R variants and early failure of antiretroviral therapy in HIV-1-infected Eritrean Immigrant. Emerging Infectious Diseases, 17(10):1966-1968.

Scherrer, A U; von Wyl, V; Joos, B; Klimkait, T; Bürgisser, P; Yerly, S; Böni, J; Ledergerber, B; Günthard, H F (2011). Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study. Journal of Infectious Diseases, 203(6):791-797.

Fehr, J; Glass, T R; Louvel, S; Hamy, F; Hirsch, H H; von Wyl, V; Böni, J; Yerly, S; Bürgisser, P; Cavassini, M; Fux, C A; Hirschel, B; Vernazza, P; Martinetti, G; Bernasconi, E; Günthard, H F; Battegay, M; Bucher, H C; Klimkait, T (2011). Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study. Journal of Translational Medicine, 9:14.

Wisskirchen, C. The cellular RNA helicase UAP56 links influenza A virus replication and the antiviral activity of Mx-proteins. 2011, University of Zurich, Faculty of Science.

von Wyl, V; Kouyos, R D; Yerly, S; Böni, J; Shah, C; Bürgisser, P; Klimkait, T; Weber, R; Hirschel, B; Cavassini, M; Staehelin, C; Battegay, M; Vernazza, P L; Bernasconi, E; Ledergerber, B; Bonhoeffer, S; Günthard, H F (2011). The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. Journal of Infectious Diseases, 204(7):1095-1103.

Scherrer, A U; von Wyl, V; Böni, J; Yerly, S; Klimkait, T; Bürgisser, P; Garzoni, C; Hirschel, B; Cavassini, M; Battegay, M; Vernazza, P L; Bernasconi, E; Ledergerber, B; Günthard, H F (2011). Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. JAIDS Journal of Acquired Immune Deficiency Syndromes, 57(1):24-31.

Dorner, M; Zucol, F; Alessi, D; Haerle, S K; Bossart, W; Weber, M; Byland, R; Bernasconi, M; Berger, C; Tugizov, S; Speck, R F; Nadal, D (2010). {beta}1 Integrin Expression Increases Susceptibility of Memory B-Cells to EBV Infection. Journal of Virology, 84(13):6667-6677.

Fritz, R D; Varga, Z; Radziwill, G (2010). CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axis. Oncogene, 29(24):3575-3582.

Simova-Curd, Stefka; Huder, J B; Boeni, J; Robert, N; Hatt, Jean-Michel (2010). Investigations on the diagnosis and retroviral aetiology of renal neoplasia in budgerigars (Melopsittacus undulatus). Avian Pathology, 39(3):161-167.

Kwok, T; Helfer, H; Alam, M I; Heinrich, J; Pavlovic, J; Moelling, K (2010). Inhibition of influenza A virus replication by short double-stranded oligodeoxynucleotides. Archives of Virology, 154(1):109-14.

Lutz, Hans; Hunsmann, Gerhard; Schüpbach, Jörg (2010). Transmission and epidemiology (chapter 8). In: Bannert, Norbert; Kurth, Reinhard. Retroviruses: Molecular Biology, Genomics and Pathogenesis. Norfolk, UK: Caister Academic Press, 217-236.

Joos, B; Rieder, P; Fischer, M; Kuster, H; Rusert, P; Trkola, A; Pillai, S K; Wong, J K; Weber, R; Günthard, H F (2010). Association between specific HIV-1 Env traits and virologic control in vivo. Infection, Genetics and Evolution, 10(3):365-372.

Schüpbach, Jörg (2010). Die vier Fragen der HIV-Diagnostik. Leading Opinions. Infektiologie, 1(1):15-17.

Pugach, P; Krarup, A; Gettie, A; Kuroda, M; Blanchard, J; Piatak Jr, M; Lifson, J D; Trkola, A; Robbiani, M (2010). In vivo binding and retention of CD4-specific DARPin 57.2 in macaques. PLoS ONE, 5(8):e12455.

Berlinger, L. The impact of neutralizing antibodies on HIV-1 attachment and entry. 2010, ETHZ, Faculty of Science.

Abela, I A; Reynell, L; Trkola, A (2010). Therapeutic antibodies in HIV treatment - classical approaches to novel advances. Current Pharmaceutical Design, 16(33):3754-3766.

Mofenson, Lynne M; Sherman, Gayle; Penazzato, Martina; de Baets, Anniek; Schüpbach, Jörg; Ramos, Artur; Fiscus, Susan; Crowley, Siobhan; Vercauteren, Gaby; Sands, Anita; Perez González, Mercedes; Malhotra, Bandana; Yerrakalva, Dharani; Anagbo, Victoria; Girvin, Sally; Kirkwood, John (2010). WHO recommendations on the diagnosis of HIV infection in infants and children. Geneva: World Health Organisation (WHO), Department of HIV/AIDS.

Clerc, O; Cavassini, M; Böni, J; Schüpbach, J; Bürgisser, P (2009). Prolonged seroconversion in an elite controller of HIV-1 infection. Journal of Clinical Virology, 46(4):371-373.

Hessell, A J; Poignard, P; Hunter, M; Hangartner, L; Tehrani, D M; Bleeker, W K; Parren, P W H I; Marx, P A; Burton, D R (2009). Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nature Medicine, 15(8):951-954.

Gaspert, A; Lüthi, B; Mueller, N J; Bossart, W; Heim, A; Wüthrich, R P; Fehr, T (2009). Subacute allograft failure with dysuria and hematuria in a kidney transplant recipient. American Journal of Kidney Diseases, 54(1):154-158.

Magnus, C; Rusert, P; Bonhoeffer, S; Trkola, A; Regoes, R R (2009). Estimating the stoichiometry of HIV entry. Journal of Virology, 83(3):1523-1531.

Geuking, M B; Weber, J; Dewannieux, M; Gorelik, E; Heidmann, T; Hengartner, H; Zinkernagel, R M; Hangartner, L (2009). Recombination of retrotransposon and exogenous RNA virus results in nonretroviral cDNA integration. Science, 323(5912):393-396.

Müller, V; von Wyl, V; Yerly, S; Böni, J; Klimkait, T; Bürgisser, P; Ledergerber, B; Günthard, H F; Bonhoeffer, S (2009). African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study. AIDS, 23(10):1269-1276.

Hessell, A J; Rakasz, E G; Poignard, P; Hangartner, L; Landucci, G; Forthal, D N; Koff, W C; Watkins, D I; Burton, D R (2009). Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. PLoS Pathogens, 5(5):e1000433.

Schüpbach, Jörg (2009). Chapter 32 Human Retroviruses, HIV and HTLV. In: Specter, Steven; Hodinka, R L; Young, S A; Wiedbrauk, D L. Clinical Virology Manual. Washington D.C.: ASM Press, American Society for Microbiology, 578-629.

Rusert, P; Mann, A; Huber, M; von Wyl, V; Gunthard, H F; Trkola, A (2009). Divergent effects of cell environment on HIV entry inhibitor activity. AIDS, 23(11):1319-1327.

Mann, A M; Rusert, P; Berlinger, L; Kuster, H; Günthard, H F; Trkola, A (2009). HIV sensitivity to neutralization is determined by target and virus producer cell properties. AIDS, 23(13):1659-1667.

Günthard, H F; Huber, M; Kuster, H; Shah, C; Schüpbach, J; Trkola, A; Böni, J (2009). HIV-1 superinfection in an HIV-2-infected woman with subsequent control of HIV-1 plasma viremia. Clinical Infectious Diseases, 48(11):e117-e120.

Ghielmetti, M; Millard, A L; Haeberli, L; Bossart, W; Seebach, J D; Schneider, M K J; Mueller, N J (2009). Human CMV infection of porcine endothelial cells increases adhesion receptor expression and human leukocyte recruitment. Transplantation, 87(12):1792-1800.

von Wyl, V; Yerli, S; Böni, J; Bürgisser, P; Klimkait, T; Battegay, M; Bernasconi, E; Cavassini, M; Furrer, H; Hirschel, B; Vernazza, P; Francioli, P; Bonhoeffer, S; Ledergerber, B; Günthard, H (2009). Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. Clinical Infectious Diseases, 48(7):979-987.

Scherrer, A U; Hasse, B; von Wyl, V; Yerly, S; Böni, J; Bürgisser, P; Klimkait, T; Bucher, H C; Ledergerber, B; Günthard, H F (2009). Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS). HIV Medicine, 10(10):647-656.

Daneel, S; Schüpbach, J; Gebhardt, M; Werner, M; Staub, R; Vernazza, P (2008). A prospective evaluation of the feasibility and utility of additional tools to obtain information from recently diagnosed HIV infected patients. Swiss Medical Weekly, 138(31-32):453-458.

Erikstrup, C; Kallestrup, P; Zinyama-Gutsire, R B; Gomo, E; Lüneborg-Nielsen, M; Gerstoft, J; Schüpbach, J; Ullum, H; Katzenstein, T L (2008). p24 as a predictor of mortality in a cohort of HIV-1-infected adults in rural Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 48(3):345-349.

Schüpbach, Jörg (2008). HIV/AIDS: Erfolge, Misserfolge und neue Ziele der Forschung. BioFokus, 18(77):1-11.

Damond, F; Benard, A; Ruelle, J; Alabi, A; Kupfer, B; Gomes, P; Rodes, B; Albert, J; Böni, J; Garson, J; Ferns, B; Matheron, S; Chene, G; Brun-Vezinet, F (2008). Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006. Journal of Clinical Microbiology, 46(6):2088-2091.

HIV Cohort Study, Switzerland; von Wyl, V; Yerly, S; Klimkait, T; Böni, J; Bürgisser, P; Battegay, M; Bernasconi, E; Cavassini, M; Furrer, H; Hirschel, B; Vernazza, P L; Rickenbach, M; Ledergerber, B; Guenthard, H F (2008). Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical Infectious Diseases, 46:1299-1309.

Meerbach, A; Wutzler, P; Haefer, R; Zintl, F; Gruhn, B (2008). Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease. Journal of Medical Virology, 80(3):441-454.

Joos, B; Fischer, M; Kuster, H; Pillai, S K; Wong, J K; Böni, J; Hirschel, B; Weber, R; Trkola, A; Günthard, H F (2008). HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 105(43):16725-16730.

Schüpbach, J; Gebhardt, M D; Tomasik, Z; Niederhauser, C; Yerly, S; Bürgisser, P; Matter, L; Gorgievski, M; Dubs, R; Schultze, D; Steffen, I; Andreutti, C; Martinetti, G; Güntert, B; Staub, R; Daneel, S; Vernazza, P (2007). Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation. PLoS Medicine, 4(12):e343.

Yerly, S; von Wyl, V; Ledergerber, B; Böni, J; Schüpbach, J; Bürgisser, P; Klimkait, T; Rickenbach, M; Kaiser, L; Günthard, H F; Perrin, L (2007). Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS, 21(16):2223-2229.

von Wyl, V; Yerly, S; Böni, J; Bürgisser, P; Klimkait, T; Battegay, M; Furrer, H; Telenti, A; Hirschel, B; Vernazza, P L; Bernasconi, E; Rickenbach, M; Perrin, L; Ledergerber, B; Günthard, H F; Swiss HIV Cohort Study (2007). Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Archives of Internal Medicine, 167(16):1782-1790.

Hessell, A J; Hangartner, L; Hunter, M; Havenith, C E G; Beurskens, F J; Bakker, J M; Lanigan, C M S; Landucci, G; Forthal, D N; Parren, P W H I; Marx, P A; Burton, D R (2007). Fc receptor but not complement binding is important in antibody protection against HIV. Nature, 449(7158):101-104.

Joos, B; Fischer, M; Schweizer, A; Kuster, H; Böni, J; Wong, J K; Weber, R; Trkola, A; Gunthard, H F (2007). Positive in vivo selection of the HIV-1 envelope protein gp120 occurs at surface-exposed regions. Journal of Infectious Diseases, 196(2):313-320.

Knuchel, M C; Jullu, B; Shah, C; Tomasik, Z; Stoeckle, M P; Speck, R F; Nadal, D; Mshinda, H; Böni, J; Tanner, M; Schüpbach, J (2007). Adaptation of the Ultrasensitive HIV-1 p24 Antigen Assay to Dried Blood Spot Testing. Journal of Acquired Immune Deficiency Syndromes, 44(3):247-253.

Bisset, L R; Böni, J; Lutz, H; Schüpbach, J (2007). Lack of evidence for PERV expression after apoptosis-mediated horizontal gene transfer between porcine and human cells. Xenotransplantation, 14(1):13-24.

Torres, J R; Torres-Viera, M A; Schupbach, J; Rangel, H R; Pujol, F H (2007). Non-immune thrombocytopenia responsive to antiretroviral therapy and HIV-2 infection. Journal of Infection, 54(1):e21-e24.

Sendi, P; Günthard, H F; Simcock, M; Ledergerber, B; Schüpbach, J; Battegay, M (2007). Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure. PLoS ONE, 2(1):e173.

Lötscher, M; Recher, M; Lang, K S; Navarini, A; Hunziker, L; Santimaria, R; Glatzel, M; Schwarz, P; Böni, J; Zinkernagel, R M (2007). Induced prion protein controls immune-activated retroviruses in the mouse spleen. PLoS ONE, 2(11):e1158.

Tehe, A; Maurice, C; Hanson, D L; Borget, M Y; Abiola, N; Maran, M; Yavo, D; Tomasik, Z; Böni, J; Schüpbach, J; Nkengasong, J N (2006). Quantification of HIV-1 p24 by a highly improved ELISA: An alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Côte d'Ivoire. Journal of Clinical Virology, 37(3):199-205.

Schüpbach, J; Tomasik, Z; Knuchel, M C; Opravil, M; Günthard, H F; Nadal, D; Böni, J (2006). Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART. Journal of Medical Virology, 78(8):1003-1010.

Böni, J; Schüpbach, J; Rickenbach, M (2006). Rabbit retrotransposon sequences undetectable in blood donors and lymphoma patients of the Swiss HIV Cohort Study. AIDS Research and Human Retroviruses, 22(6):499-500.

Seemayer, C A; Böni, J; Steiger, J; Schüpbach, J; Mihatsch, M J (2006). No indication for activation of exogenous retroviruses in patients with renal allograft rejection. Clinical Nephrology, 65(5):324-327.

Knuchel, M C; Tomasik, Z; Speck, R F; Lüthy, R; Schüpbach, J (2006). Ultrasensitive quantitative HIV-1 p24 antigen assay adapted to dried plasma spots to improve treatment monitoring in low-resource settings. Journal of Clinical Virology, 36(1):64-67.

Brinkhof, M W G; Böni, J; Steiner, F; Tomasik, Z; Nadal, D; Schüpbach, J (2006). Evaluation of p24-based antiretroviral treatment monitoring in pediatric HIV-1 infection: prediction of the CD4+ T-cell changes between consecutive visits. JAIDS Journal of Acquired Immune Deficiency Syndromes, 41(5):557-562.

Simcock, M; Sendi, P; Ledergerber, B; Keller, T; Schüpbach, J; Battegay, M; Günthard, H F (2006). A longitudinal analysis of healthcare costs after treatment optimization following genotypic antiretroviral resistance testing: does resistance testing pay off? Antiviral Therapy, 11(3):305-314.

Jennings, C; Fiscus, S A; Crowe, S M; Danilovic, A D; Morack, R J; Scianna, S; Cachafeiro, A; Brambilla, D J; Schüpbach, J; Stevens, W; Respess, R; Varnier, O E; Corrigan, G E; Gronowitz, J S; Ussery, M A; Bremer, J W (2005). Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay. Journal of Clinical Microbiology, 43(12):5950-5956.

Schüpbach, J; Günthard, H F; Joos, B; Fischer, M B; Böni, J; Tomasik, Z; Yerly, S; Perrin, L; Battegay, M; Furrer, H; Vernazza, P; Bernasconi, E; Hirschel, B (2005). HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss. JAIDS Journal of Acquired Immune Deficiency Syndromes, 40(3):250-256.

Aceto, L; Karrer, U; Grube, Ch; Oberholzer, R; Hasse, B; Presterl, E; Böni, J; Kuster, H; Trkola, A; Weber, R; Günthard, H F (2005). Die akute HIV-1-Infektion in Zürich: 2002–2004. Praxis, 94(32):1199-1205.

Joos, B; Trkola, A; Fischer, M; Kuster, H; Rusert, P; Leemann, C; Böni, J; Oxenius, A; Price, D A; Phillips, R E; Wong, J K; Hirschel, B; Weber, R; Günthard, H F (2005). Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions. Journal of Virology, 79(14):9026-9037.

Deichmann, M; Huder, J B; Kleist, C; Näher, H; Schüpbach, J; Böni, J (2005). Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant. Archives of Dermatological Research, 296(8):345-352.

Bisset, L R; Schmid-Grendelmeier, P (2005). Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Current Opinion in Pulmonary Medicine, 11(1):35-42.

Schüpbach, J (2004). SHCS und die Labordiagnostik der HIV-Infektion - von der Entwicklung des HIV Western Blot über die Virusquantifizierung zur klinisch relevanten individuellen Viruscharakterisierung. Therapeutische Umschau, 61(10):603-607.

Hofmann-Lehmann, R; Meli, M L; Dreher, U M; Gönczi, E; Deplazes, P; Braun, U; Engels, M; Schüpbach, J; Jörger, K; Thoma, R; Griot, C; Stärk, K D C; Willi, B; Schmidt, J; Kocan, K M; Lutz, H (2004). Concurrent infections with vector-borne pathogens associated with fatal hemolytic anemia in a cattle herd in Switzerland. Journal of Clinical Microbiology, 42(8):3775-3780.

Soldati, G; Lu, Z H; Vaughan, L; Polkinghorne, A; Zimmermann, D R; Huder, J B; Pospischil, A (2004). Detection of mycobacteria and chlamydiae in granulomatous inflammation of reptiles: a retrospective study. Veterinary Pathology, 41(4):388-397.

Shah, C A; Huder, J B; Böni, J; Schönmann, M; Mühlherr, J; Lutz, H; Schüpbach, J (2004). Direct evidence for natural transmission of small-ruminant lentiviruses of subtype A4 from goats to sheep and vice versa. Journal of Virology, 78(14):7518-7522.

Oxenius, A; Price, D A; Hersberger, M; Schlaepfer, E; Weber, R; Weber, M; Kundig, T M; Böni, J; Joller, H; Phillips, R E; Flepp, M; Opravil, M; Speck, R F (2004). HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load. Journal of Infectious Diseases, 189(7):1199-1208.

Shah, C A; Böni, J; Huder, J B; Vogt, H R; Mühlherr, J; Zanoni, R; Miserez, R; Lutz, H; Schüpbach, J (2004). Phylogenetic analysis and reclassification of caprine and ovine lentiviruses based on 104 new isolates: evidence for regular sheep-to-goat transmission and worldwide propagation through livestock trade. Virology, 319(1):12-26.

Böni, J; Bisset, L R; Burckhardt, J J; Joller-Jemelka, H I; Bürgisser, P; Perrin, L; Gorgievski, M; Erb, P; Fierz, W; Piffaretti, J C; Schüpbach, J (2004). Prevalence of human T-cell leukemia virus types I and II in Switzerland. Journal of Medical Virology, 72(2):328-337.

Böni, J; Shah, C A; Flepp, M; Lüthy, R; Schüpbach, J (2004). Detection of low copy numbers of HIV-1 proviral DNA in patient PBMCs by a high-input, sequence-capture PCR (Mega-PCR). Journal of Medical Virology, 72(1):1-9.

Schüpbach, J (2003). Viral RNA and p24 antigen as markers of HIV disease and antiretroviral treatment success. International Archives of Allergy and Immunology, 132(3):196-209.

Haupts, S; Ledergerber, B; Böni, J; Schüpbach, J; Kronenberg, A; Opravil, M; Flepp, M; Speck, R F; Grube, C; Rentsch, K; Weber, R; Günthard, H F (2003). Impact of genotypic resistance testing on selection of salvage regimen in clinical practice. Antiviral Therapy, 8(5):443-454.

Ribas, S G; Ondoa, P; Schüpbach, J; van der Groen, G; Fransen, K (2003). Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals. Journal of Virological Methods, 113(1):29-34.

Schüpbach, J; Böni, J; Bisset, L R; Tomasik, Z; Fischer, M; Günthard, H F; Ledergerber, B; Opravil, M (2003). HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 33(3):292-299.

Shah, C A; Böni, J; Bisset, L R; Seebach, J D; Schüpbach, J (2003). Ultra-sensitive and specific detection of porcine endogenous retrovirus (PERV) using a sequence-capture real-time PCR approach. Journal of Virological Methods, 109(2):209-216.

Hasse, B; Hummel, Y; Böni, J; Schüpbach, J; Flepp, M; Günthard, H F (2003). 25-jähriger therapienaiver Patient mit einem dreiklassenresistenten HI-Virus. Praxis, 92(13):601-605.

Sterling, T R; Hoover, D R; Astemborski, J; Vlahov, D; Bartlett, J G; Schüpbach, J (2002). Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease. Journal of Infectious Diseases, 186(8):1181-1185.

Seemayer, C A; Kolb, S A; Neidhart, M; Ohshima, S; Gay, R E; Michel, B A; Gay, S; Böni, J; Schüpbach, J (2002). Absence of inducible retroviruses from synovial fibroblasts and synovial fluid cells of patients with rheumatoid arthritis. Arthritis and Rheumatism, 46(16):2811-2813.

Huder, J B; Böni, J; Hatt, Jean-Michel; Soldati, G; Lutz, Hans; Schüpbach, Jörg (2002). Identification and characterization of two closely related unclassifiable endogenous retroviruses in pythons (Python molurus and Python curtus). Journal of Virology, 76(15):7607-7615.

Bisset, Leslie R; Lutz, Hans; Böni, Jürg; Hofmann-Lehmann, Regina; Lüthy, Ruedi; Schüpbach, Jörg (2002). Combined effect of zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) antiretroviral therapy in suppressing in vitro FIV replication. Antiviral Research, 53(1):35-45.

Schüpbach, J (2002). Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA. AIDS Reviews, 4(2):83-92.

Braun, U; Camenzind, D; Meli, M; Böni, J; Ossent, P (2001). Klinische Befunde und diagnostisches Vorgehen bei einem Milchschaf mit Visna. Schweizer Archiv für Tierheilkunde, 143(11):550-553.

Schüpbach, J; Böni, J; Flepp, M; Tomasik, Z; Joller, H; Opravil, M (2001). Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA. Journal of Medical Virology, 65(2):225-232.

Bisset, L R; Bosbach, S; Tomasik, Z; Lutz, H; Schüpbach, J; Böni, J (2001). Quantification of in vitro retroviral replication using a one-tube real-time RT-PCR system incorporating direct RNA preparation. Journal of Virological Methods, 91(2):149-155.

Schüpbach, J (2001). Induction/activation and detection of occult viral agents present in mammalian cells. In: Brown, F; Lewis, A M; Peden, K; Krause, P. Evolving Scientific and Regulatory Perspectives on Cell Substrates for Vaccine Development. Basel: Karger, 425-437.

Schüpbach, J; Tomasik, Z; Nadal, D; Ledergerber, B; Flepp, M; Opravil, M; Böni, J (2000). Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. International Journal of Antimicrobial Agents, 16(4):441-445.

Fischer, M; Günthard, H F; Opravil, M; Joos, B; Huber, W; Bisset, L R; Ott, P; Böni, J; Weber, R; Cone, R W (2000). Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy. AIDS Research and Human Retroviruses, 16(12):1135-1140.

Ledergerber, B; Flepp, M; Böni, J; Tomasik, Z; Cone, R W; Lüthy, R; Schüpbach, J (2000). Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. Journal of Infectious Diseases, 181(4):1280-1288.

Bürgisser, P; Vernazza, P; Flepp, M; Böni, J; Tomasik, Z; Hummel, U; Pantaleo, G; Schüpbach, J (2000). Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 23(2):138-144.

Böni, J; Pyra, H; Gebhardt, M; Perrin, L; Bürgisser, P; Matter, L; Fierz, W; Erb, P; Piffaretti, J C; Minder, E; Grob, P; Burckhardt, J J; Zwahlen, M; Schüpbach, J (1999). High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. JAIDS Journal of Acquired Immune Deficiency Syndromes, 22(2):174-179.

Nadal, D; Böni, J; Kind, C; Varnier, O E; Steiner, F; Tomasik, Z; Schüpbach, J (1999). Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. Journal of Infectious Diseases, 180(4):1089-1095.

Leutenegger, Christian M; Klein, D; Hofmann-Lehmann, Regina; Mislin, Caroline N; Hummel, U; Böni, J; Boretti, Felicitas S; Guenzburg, W H; Lutz, Hans (1999). Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system. Journal of Virological Methods, 78(40575):105-116.

Di Paolo, C; Hefti, H P; Meli, M; Landis, H; Pavlovic, J (1999). Intramolecular backfolding of the carboxyl-terminal end of MxA protein is a prerequisite for its oligomerization. Journal of Biological Chemistry, 274(45):32071-32078.

Holznagel, E; Hofmann-Lehmann, R; Leutenegger, C M; Allenspach, K; Huettner, S; Forster, U; Niederer, E; Joller, H; Willett, B J; Hummel, U; Rossi, G L; Schüpbach, J; Lutz, H (1998). The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progression. Journal of Virology, 72(11):9025-9033.

Schüpbach, J; Böni, J (1998). Sensitivity of heat-denatured p24 antigen in the diagnosis of pediatric HIV infection. Journal of Acquired Immune Deficiency Syndromes, 18(4):399-400.

Schüpbach, J (1998). Xenotransplantation and viruses - the model of retroviruses. Swiss Medical Weekly, 128(24):935-943.

Kind, C; Rudin, C; Siegrist, C A; Wyler, C A; Biedermann, K; Lauper, U; Irion, O; Schüpbach, J; Nadal, D (1998). Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group. AIDS, 12(2):205-210.

Conrad, B; Weissmahr, R N; Böni, J; Arcari, R; Schüpbach, J; Mach, B (1997). A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell, 90(2):303-313.

Böni, J; Opravil, M; Tomasik, Z; Rothen, M; Bisset, L; Grob, P J; Lüthy, R; Schüpbach, J (1997). Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS, 11(6):F47-F52.

Weissmahr, R N; Schüpbach, J; Böni, J (1997). Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avian retrovirus EAV-0 RNA. Journal of Virology, 71(4):3005-3012.

Schüpbach, J; Flepp, M; Pontelli, D; Tomasik, Z; Lüthy, R; Böni, J (1996). Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. AIDS, 10(10):1085-1090.

Jendis, J; Strack, B; Volkmann, S; Böni, J; Mölling, K (1996). Inhibition of replication of fresh HIV type 1 patient isolates by a polypurine tract-specific self-complementary oligodeoxynucleotide. AIDS Research and Human Retroviruses, 12(12):1161-1168.

Schüpbach, J; Pyra, H; Jendis, J; Tomasik, Z; Böni, J (1996). Isolation of an in vitro transmissible agent with reverse transcriptase activity from a blood donor with a borderline-positive HIV-1 serology for more than five years. Clinical and Diagnostic Virology, 5(2-3):197-203.

Schüpbach, J (1996). Licencing of diagnostic HIV kits-to keep a sensible standpoint in an area of permanent revolution. Clinical and Diagnostic Virology, 5(2-3):137-146.

Böni, J; Pyra, H; Schüpbach, J (1996). Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay. Journal of Medical Virology, 49(1):23-28.

Böni, J; Stalder, J; Reigel, F; Schüpbach, J (1996). Detection of reverse transcriptase activity in live attenuated virus vaccines. Clinical and Diagnostic Virology, 5(1):43-53.

Pyra, H; Böni, J; Schüpbach, J (1994). Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 91(4):1544-1548.

Böni, J; Schüpbach, J (1993). Sensitive and quantitative detection of PCR-amplified HIV-1 DNA products by an enzyme linked immunoassay following solution hybridization with two differently labelled oligonucleotide probes. Molecular and Cellular Probes, 7(5):361-371.

Böni, J; Emmerich, B S; Leib, S L; Wiestler, O D; Schüpbach, J; Kleihues, P (1993). PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology, 43(9):1813-1817.

Schüpbach, J; Böni, J (1993). Quantitative and sensitive detection of immune-complexed and free HIV antigen after boiling of serum. Journal of Virological Methods, 43(2):247-256.

This list was generated on Thu Nov 23 22:11:56 2017 CET.